ST. PAUL, Minn. – Minnesota Democratic lawmakers want to create an independent board to regulate excessive prescription drug prices following a bipartisan effort last year to make insulin more affordable.
The legislation would establish an independent board and an advisory council that would review the costs of new brand-name prescription drugs. The board would set upper payment limits for drug prices it determines are unaffordable.
The legislation follows the Alec Smith Insulin Affordability Act that established a safety net program for diabetics who can’t afford the life-saving drug.